Benjamin L. Palleiko

Benjamin L. Palleiko is a seasoned executive with a diverse background in both financial management and operational leadership. Before his tenure at KALV, he developed a robust foundation through various roles in the pharmaceutical and financial sectors, including serving as the co-Founder and Chief Executive Officer of Cielo Therapeutics, Inc. and working as an investment banker with Robertson Stephens and SunTrust Bank.

His career at KALV began when he joined as the Chief Financial Officer in August 2016, and he quickly advanced within the organization. Over time, he was entrusted with greater responsibilities, serving as the Chief Business Officer starting in March 2019, and later as President in January 2023. His steady rise through these ranks is a testament to his leadership and strategic acumen.

In addition to his executive roles, Palleiko also brings a strong educational background and military discipline to his work. With degrees in economics, finance, and international relations, and having served as a Naval Aviator in the U.S. Navy, he combines academic excellence with real-world experience. His contributions to KALV have been pivotal in driving growth and preparing the company for regulatory milestones, reflecting a well-rounded blend of strategic vision and operational expertise.

No information available on performance compensation for 2024